Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows From Operating Activities    
Net income (loss) $ 351 $ (2,247)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 356 781
Interest accretion expense 35 121
Amortization of deferred financing fees 14 10
Stock-based compensation 192 302
ESPP expense 23
Change in fair value of note payable (33) (107)
Mark to market on warrants (63)
Other changes in operating assets and liabilities:    
Accounts receivable 317 (1,083)
Other current assets 107 (83)
Other long-term assets (1)
Accounts payable 532 1,235
Accrued salaries and bonus (568) 377
Accrued liabilities (249) (556)
Long-term liabilities 79 37
Net cash provided by (used in) operating activities 1,133 (1,254)
Cash Flows From Investing Activity    
Purchase of property and equipment (65) (19)
Net cash used in investing activities (65) (19)
Cash Flows From Financing Activities    
Issuance of common stock, net of expenses 59
(Payments) borrowings on line of credit (300) 1,000
Net cash (used in) provided by financing activities (300) 1,059
Net increase (decrease) in cash, cash equivalents and restricted cash 768 (214)
Cash, cash equivalents and restricted cash from continuing operations– beginning 4,828 2,922
Cash, cash equivalents and restricted cash from discontinued operations– beginning 392
Cash, cash equivalents and restricted cash – beginning 4,828 3,314
Cash, cash equivalents and restricted cash from continuing operations– ending 4,828 2,813
Cash, cash equivalents and restricted cash from discontinued operations– ending 287
Cash, cash equivalents and restricted cash – ending $ 5,596 $ 3,100